301281 科源制药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.6068.32519.20220.23622.330
总资产报酬率 ROA (%)1.4487.26215.07115.35814.320
投入资产回报率 ROIC (%)1.5828.15418.63519.47418.535

边际利润分析
销售毛利率 (%)41.48247.25240.93642.10150.057
营业利润率 (%)16.70017.90022.16721.34121.417
息税前利润/营业总收入 (%)15.24416.73121.58121.42722.814
净利润/营业总收入 (%)14.71417.21220.61118.57318.703

收益指标分析
经营活动净收益/利润总额(%)93.92383.43496.57492.52591.654
价值变动净收益/利润总额(%)6.70815.9830.0000.0000.000
营业外收支净额/利润总额(%)-5.163-0.4780.1310.1073.045

偿债能力分析
流动比率 (X)6.6177.9072.6171.8361.771
速动比率 (X)5.8256.9351.9871.0561.060
资产负债率 (%)10.1109.45120.26122.97125.494
带息债务/全部投入资本 (%)-0.484-0.520-1.119-1.5900.655
股东权益/带息债务 (%)-20,357.579-18,929.749-8,633.711-6,137.06814,441.015
股东权益/负债合计 (%)888.494958.081393.551335.331292.245
利息保障倍数 (X)-23.969-15.447-35.060340.45931.525

营运能力分析
应收账款周转天数 (天)36.82532.43824.03117.14129.257
存货周转天数 (天)109.037134.162106.221116.260129.268